These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104078)

  • 21. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
    Rudman D; Patterson JH; Gibbas DL
    J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New paradigms for growth hormone therapy in children.
    Wetterau L; Cohen P
    Horm Res; 2000; 53 Suppl 3():31-6. PubMed ID: 10971101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Justified and unjustified use of growth hormone.
    van der Lely AJ
    Postgrad Med J; 2004 Oct; 80(948):577-80. PubMed ID: 15466991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.
    Kanzaki S; Hosoda K; Moriwake T; Tanaka H; Kubo T; Inoue M; Higuchi J; Yamaji T; Seino Y
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1104-9. PubMed ID: 1400878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papers presented at International Novo Nordisk Symposium on Growth. Santiago de Compostela, Spain, October 1995.
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():233-374. PubMed ID: 9019391
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
    Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Growth hormone-releasing peptides (GHRP) and their analogues].
    Korbonits M; Grossman AB
    Orv Hetil; 1996 Nov; 137(45):2503-9. PubMed ID: 8999395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New findings and the potential use of the growth hormone].
    Sotos JF
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():166-9. PubMed ID: 1636958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of GH: a rationale for continued GH treatment of GH-deficient adults after cessation of linear growth.
    Juul A; Jørgensen JO; Christiansen JS; Müller J; Skakkeboek NE
    Horm Res; 1995; 44 Suppl 3():64-72. PubMed ID: 8719443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological findings in growth hormone-treated patients.
    Wit JM; Kooijman R; Rijkers GT; Zegers BJ
    Horm Res; 1993; 39(3-4):107-10. PubMed ID: 8262470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth hormone deficiency: diagnosis and treatment].
    de Muinck Keizer-Schrama SM; Rikken B
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):147-54. PubMed ID: 1360175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of GH on erythropoiesis in vivo].
    Ardizzi A; Guzzaloni G; Grugni G; Moro D; Calò G; Mazzilli G; Tonelli E; Morabito F
    Minerva Endocrinol; 1993 Jun; 18(2):83-5. PubMed ID: 8289754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone therapy in Canada: end of one era and beginning of another.
    Dean HJ; Friesen HG
    CMAJ; 1986 Aug; 135(4):297-301. PubMed ID: 3089574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of growth hormone in non-growth hormone deficient children.
    Sood A; Menon PS
    Natl Med J India; 1998; 11(5):222-5. PubMed ID: 10997170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.
    Sartorio A; Conti A; Monzani M; Faglia G
    J Endocrinol Invest; 1995 Feb; 18(2):109-12. PubMed ID: 7543124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study.
    Ishii H; Shimatsu A; Nishinaga H; Murai O; Chihara K
    Growth Horm IGF Res; 2017 Oct; 36():36-43. PubMed ID: 28923784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone in the treatment of children with short stature.
    Pediatrics; 1983 Dec; 72(6):891-4. PubMed ID: 6646934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH.
    Chalew SA; Armour KM; Levin PA; Thorner MO; Kowarski AA
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1110-5. PubMed ID: 3084533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z; Limoni Y; Lieberman E
    Horm Res; 1991; 35(3-4):95-8. PubMed ID: 1806474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.